Which of the following announced a ₹5,000 crore financial outlay for research and innovation in India's pharmaceutical and med-tech sectors?

Correct option is C

The correct answer is (c) PRIP Scheme

Explanation:
• The Promotion of Research and Innovation in Pharma-MedTech (PRIP) scheme was launched with a total outlay of ₹5,000 crore.
• The scheme aims to transform the Indian pharmaceutical sector from 'volume-based' to 'value-based' innovation.
• It focuses on strengthening the research infrastructure and providing financial support for R&D projects.
• The objective is to encourage industry-academia linkage to develop high-value products like complex generics and biologics.
• It is implemented by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.

Information Booster:
• The scheme identifies 'Centers of Excellence' (CoEs) within National Institutes of Pharmaceutical Education and Research (NIPERs).
• India is known as the 'Pharmacy of the World', being the largest provider of generic drugs globally.

Additional Knowledge:
Smart Cities Mission (Option a)
• Focused on urban renewal and infrastructure across 100 cities, not specific to pharmaceutical R&D.
Startup India (Option b)
• A broader initiative to foster entrepreneurship across all sectors, not limited to a ₹5,000 crore pharma-specific fund.
Atmanirbhar Bharat Abhiyan (Option d)
• The overarching umbrella campaign for self-reliance; PRIP is a specific scheme functioning under this vision.

So the correct answer is (c)